miocamycin has been researched along with clindamycin in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mitsuhashi, S; Okubo, T; Terasawa, T; Watanabe, M | 1 |
| Catania, S; De Bac, C; De Vito, ML; Mascellino, MT | 1 |
| Iwamoto, Y; Miyake, Y; Okuda, K; Suginaka, H; Tsuruda, K | 1 |
| Cornaglia, G; Fontana, R; Ligozzi, M; Lo Cascio, G; Masala, L; Mazzariol, A; Orefici, G | 1 |
| Hirakata, Y; Igari, J; Kaku, M; Matsuda, J; Misawa, N; Mori, T; Murase, M; Nakamura, A; Nakamura, Y; Oguri, T; Shimada, J; Shimoura, M; Shitara, M; Tachibana, Y; Tazawa, S; Ugajin, K; Umezu, S | 1 |
| Alós, JI; Aracil, B; Gómez-Garcés, JL; Oteo, J; Torres, C | 1 |
| Hirai, K; Hiramatsu, K; Kishi, K; Murakami, J; Nasu, M; Yamasaki, T | 1 |
| Alós, JI; Aracil, B; Gómez-Garcés, JL; Oteo, J | 1 |
| Berlutti, F; Scazzocchio, F; Selan, L; Tarantino, U; Thaller, MC | 1 |
| Min, YH | 1 |
10 other study(ies) available for miocamycin and clindamycin
| Article | Year |
|---|---|
In vitro activity of YM133, a new semisynthesized macrolide.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Clindamycin; Drug Resistance, Microbial; Erythromycin; Josamycin; Microbial Sensitivity Tests; Miocamycin; Oleandomycin | 1991 |
Erythromycin, miocamycin and clindamycin towards adhesivity and phagocytosis of gram-positive bacteria.
Topics: Bacterial Adhesion; Cells, Cultured; Clindamycin; Epithelial Cells; Epithelium; Erythromycin; Gram-Positive Bacteria; Humans; Leucomycins; Microbial Sensitivity Tests; Miocamycin; Mouth Mucosa; Mutagens; Neutrophils; Opsonin Proteins; Phagocytosis; Urinary Tract | 1988 |
In vitro activity of tetracyclines, macrolides, quinolones, clindamycin and metronidazole against periodontopathic bacteria.
Topics: Aggregatibacter actinomycetemcomitans; Anti-Bacterial Agents; Anti-Infective Agents; Antitrichomonal Agents; Clindamycin; Erythromycin; Fluoroquinolones; Metronidazole; Microbial Sensitivity Tests; Minocycline; Miocamycin; Naphthyridines; Ofloxacin; Porphyromonas gingivalis; Prevotella intermedia; Quinolones; Tetracycline | 1995 |
Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy. The Italian Surveillance Group for Antimicrobial Resistance.
Topics: Anti-Bacterial Agents; Child; Clindamycin; DNA, Bacterial; Drug Resistance, Microbial; Erythromycin; Humans; Italy; Methyltransferases; Miocamycin; Streptococcal Infections; Streptococcus pyogenes | 1998 |
[Antimicrobial activities of roxithromycin against recently obtained clinical isolates].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cephalosporins; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Humans; Leucomycins; Methicillin Resistance; Miocamycin; Moraxella catarrhalis; Mycoplasma pneumoniae; Penicillin Resistance; Penicillins; Roxithromycin; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus agalactiae; Streptococcus pneumoniae; Streptococcus pyogenes | 1997 |
High prevalence of erythromycin-resistant, clindamycin/miocamycin-susceptible (M phenotype) Streptococcus pyogenes: results of a Spanish multicentre study in 1998. Spanish Group for the Study of Infection in the Primary Health Care Setting.
Topics: Adult; Anti-Bacterial Agents; Child; Clindamycin; Drug Resistance, Microbial; Erythromycin; Humans; Microbial Sensitivity Tests; Miocamycin; Prevalence; Spain; Streptococcal Infections; Streptococcus pyogenes | 2000 |
Macrolides and clindamycin suppress the release of Shiga-like toxins from Escherichia coli O157:H7 in vitro.
Topics: Animals; Anti-Bacterial Agents; Bacterial Toxins; Cefdinir; Cephalosporins; Chlorocebus aethiops; Clindamycin; Dose-Response Relationship, Drug; Escherichia coli O157; Fosfomycin; Humans; Latex Fixation Tests; Levofloxacin; Microbial Sensitivity Tests; Miocamycin; Ofloxacin; Roxithromycin; Shiga Toxin 1; Shiga Toxin 2; Time Factors; Vero Cells | 2000 |
Significant increase in the prevalence of erythromycin-resistant, clindamycin- and miocamycin-susceptible (M phenotype) Streptococcus pyogenes in Spain.
Topics: Anti-Bacterial Agents; Cephalosporins; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Humans; Microbial Sensitivity Tests; Miocamycin; Phenotype; Spain; Streptococcal Infections; Streptococcus pyogenes | 2003 |
Antibiotic susceptibility of slime-producing isolates from orthopedic patients.
Topics: Anti-Bacterial Agents; Cefotaxime; Clindamycin; Colony-Forming Units Assay; Humans; Imipenem; Microbial Sensitivity Tests; Miocamycin; Myxococcales; Ofloxacin; Orthopedic Procedures; Postoperative Complications | 1989 |
Solithromycin Can Specifically Induce Macrolide-Lincosamide-Streptogramin B Resistance.
Topics: Anti-Bacterial Agents; Bacillus subtilis; Bacterial Proteins; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Escherichia coli; Gene Expression Regulation, Bacterial; Genes, Reporter; Genetic Engineering; Ketolides; Lac Operon; Lincosamides; Macrolides; Methyltransferases; Microbial Sensitivity Tests; Miocamycin; Staphylococcus aureus; Streptogramin B; Transformation, Bacterial; Triazoles | 2020 |